Return
Red blood cells stored in anticoagulant versus additive solution for large volume transfusions in pediatric patients undergoing cardiopulmonary bypass
N
M
DOI:10.1111/trf.70297.png)
Abstract
En 中文
The safety of red blood cells (RBCs) in additive solutions (AS) for large-volume transfusion (LVT) in pediatrics remains understudied. This study examines the laboratory and clinical impact of CPD-stored products versus CP2D/AS-3 products in pediatric patients receiving LVT during cardiac surgery.
Keywords:
AS-3 additive solution
Cardiopulmonary bypass
Citrate-phosphate-dextrose (CPD)
Electrolyte abnormalities
Large-volume transfusion
Pediatric cardiac surgery
Red blood cell additive solutions
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
2
Papers:
718
Citations:
1.3W
